March 20, 2019
Loading Events

« All Events

Adaptive Designs in Clinical Trials conference 2019

April 1 - April 2

SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials – demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology.

Hosting in depth presentations from regulatory agencies, researchers and biostatisticians, the meeting will cover how personalized medicine, platform trials, response-adaptive randomization, signature designs, estimand framework, Bayesian methods and digital innovation are revolutionizing the drug development process both in Europe and North America.
The benefits of attending:

At this year’s conference there will once again be an array of networking opportunities:

*   Meet and network with key industry and thought leaders shaping state of the art adaptive design techniques
*   More than 4 hours of networking during the conference days
*   Engage with an array of vendors, with leading solution providers, Mevia and GCE Solutions among those exhibiting last year

Key reasons to attend:

*   See how the regulatory environment for adaptive drug design is shifting across the continent with insights from the MHRA, Amgen, AstraZeneca and Berry Consulting
*   Explore the therapeutic potential of adaptive designs with real-world examples from H.Lundbeck, GSK Vaccines, Pfizer and Novartis
*   Listen to how the latest platform trial case studies – such as that of the EPAD project and the MS Society initiative, are impacting pharmaceutical development
*   Delve into the long-standing discussion of Bayesian vs. frequentist designs
*   Discover the latest research in response-adaptive designs: trials for rare diseases and looking forward

Featured Speakers:
• Sandeep Menon, Vice President and Head of Early Clinical Development, Pfizer
• Simon Wandel, Associate Director, Statistical Methodology and Consulting, Novartis
• Solange Corriol-Rohou, Senior Director Regulatory Addairs & Policy, Europe, AstraZeneca*
• Christine Fletcher, Executive Director Biostatistics, Amgen
• Philip Hougaard, Vice President Biometrics, H. Lundbeck
• Beatrice Panico, Medical Assessor, MHRA
• Kaspar Rufi bach, Principal Statistical Scientist, Roche
• Andrea Callegaro, Senior Manager, Biostatistician, GSK Vaccines

EARLY-BIRD RATES:

*   BOOK BY 14th DECEMBER AND SAVE £400
*   BOOK BY 31ST JANUARY AND SAVE £200
*   BOOK BY 14H FEBRUARY AND SAVE £100

LinkedIn: @SMi Pharma Twitter: #SMi & #smiadaptivedesigns

Details

Start:
April 1
End:
April 2
Website:
http://www.adaptivedesigns.co.uk/pharmahqwl

Organizer

SMI
Phone:
+44 (0) 20 7827 6088
Email:
hsidhu@smi-online.co.uk

Venue

Holiday Inn Kensington Forum, London, UK

To ensure you get the best experience on our website, we use cookies to analyze traffic and for ads measurements purposes including for serving Industry-based ads. By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close